{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:26:17Z","timestamp":1776205577878,"version":"3.50.1"},"reference-count":29,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1136\/bjophthalmol-2015-306930","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T04:03:54Z","timestamp":1454040234000},"page":"1547-1550","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up"],"prefix":"10.1136","volume":"100","author":[{"given":"Morgane","family":"Straub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain M","family":"Bron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurore","family":"Muselier-Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Creuzot-Garcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,1,28]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2015-306930-1","first-page":"221","article-title":"Report of the national eye institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"key-10.1136\/bjophthalmol-2015-306930-2","first-page":"S102","article-title":"Prevalence, burden, and pharmacoeconomics of dry eye disease","volume":"14","author":"Pflugfelder","year":"2008","journal-title":"Am J Manag Care"},{"key":"key-10.1136\/bjophthalmol-2015-306930-3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.85.2.147","article-title":"Tear film MMP accumulation and corneal disease","volume":"85","author":"Smith","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/112067211002000405","article-title":"Evaluation of the effect of topical cyclosporine A with impression cytology in dry eye patients","volume":"20","author":"Y\u00fcksel","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306930-6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"key-10.1136\/bjophthalmol-2015-306930-8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archopht.122.3.369","article-title":"Incidence of dry eye in an older population","volume":"122","author":"Moss","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-9","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.clinthera.2006.11.016","article-title":"Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys","volume":"28","author":"Trattler","year":"2006","journal-title":"Clin Ther"},{"key":"key-10.1136\/bjophthalmol-2015-306930-10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1542-0124(12)70084-8","article-title":"Design and conduct of clinical trials: report of the Clinical Trials Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"key-10.1136\/bjophthalmol-2015-306930-11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00003226-200201000-00002","article-title":"Pharmacologic treatments for dry eye: a worthwhile investment?","volume":"21","author":"Novack","year":"2002","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-306930-12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","article-title":"Dysfunctional tear syndrome: a Delphi approach to treatment recommendations","volume":"25","author":"Behrens","year":"2006","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-306930-13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jop.2009.0091","article-title":"Topical cyclosporine 0.05% for the prevention of dry eye disease progression","volume":"26","author":"Rao","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-306930-14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00055735-200408000-00004","article-title":"Dry eye diagnosis and management in 2004","volume":"15","author":"Perry","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A","volume":"18","author":"Utine","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.1136\/bjophthalmol-2015-306930-16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes","volume":"118","author":"Kunert","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00003226-200007000-00018","article-title":"Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion","volume":"19","author":"Turner","year":"2000","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-306930-18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bjo.2005.070888","article-title":"Topical ciclosporin in the treatment of ocular surface disorders","volume":"89","author":"Tatlipinar","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","article-title":"Antiinflammatory therapy for dry eye","volume":"137","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-20","first-page":"S88","article-title":"Management of dry eye disease","volume":"14","author":"Lemp","year":"2008","journal-title":"Am J Manag Care"},{"key":"key-10.1136\/bjophthalmol-2015-306930-21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ophtha.2006.05.077","article-title":"Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment","volume":"114","author":"Wilson","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306930-22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1185\/030079905X50615","article-title":"The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca","volume":"21","author":"Stonecipher","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"key-10.1136\/bjophthalmol-2015-306930-23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jop.2006.22.47","article-title":"Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis","volume":"22","author":"Rubin","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-306930-24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/ICO.0b013e3181acf68d","article-title":"Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy","volume":"29","author":"Toker","year":"2010","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-306930-25","first-page":"2195","article-title":"Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model","volume":"18","author":"Liang","year":"2012","journal-title":"Mol Vis"},{"key":"key-10.1136\/bjophthalmol-2015-306930-26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/jop.2011.0073","article-title":"Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal","volume":"27","author":"Rao","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-306930-27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2013-304072","article-title":"Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease","volume":"98","author":"Sacchetti","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/mi.2013.61","article-title":"CD8(+) cells regulate the T helper-17 response in an experimental murine model of Sj\u00f6gren syndrome","volume":"7","author":"Zhang","year":"2014","journal-title":"Mucosal Immunol"},{"key":"key-10.1136\/bjophthalmol-2015-306930-29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2015-306930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:50:40Z","timestamp":1601110240000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2015-306930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,28]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,10,21]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1136\/bjophthalmol-2015-306930"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306930","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,28]]}}}